Additionally, consistent with inhibition of SOX4, a gene promoting metastasis and cell invasion22, both Metformin and Bortezomib significantly reduced the invasion characteristics of cancer cells induced with Wnt3a treatment (Supplementary Fig. S6c). Here, WNT3A is linked to cancer.